Onbo subcutaneous injection 100mg syringe, from Eli Lilly Japan, contains mirikizumab (genetical recombination). This IL-23 inhibitor is used to treat adults with moderate-to-severe ulcerative colitis and Crohn’s disease. It is supplied as 100mg x 1mL tube with YJ code 2399407G1024.
Onbo subcutaneous injection 100mg syringe
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).